Hematology Diagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Hematology Diagnostics Market

1.1. Definition and Scope

1.1.1. Definition of Hematology Diagnostics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Hematology Diagnostics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Hematology Diagnostics Market By Product

1.2.3. Hematology Diagnostics Market By Test Type

1.2.4. Hematology Diagnostics Market By End-Use

1.2.5. Hematology Diagnostics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Hematology Diagnostics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Hematology Diagnostics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Hematology Diagnostics Market By Product

5.1. Introduction

5.2. Hematology Diagnostics Revenue By Product

5.2.1. Hematology Diagnostics Revenue (USD Billion) and Forecast, By Product, 2018-2030

5.2.2. Instrument

5.2.2.1. Instrument Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.2. Analyzers

5.2.2.2.1. Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.3. Flow Cytometers

5.2.2.3.1. Flow Cytometers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.4. Others

5.2.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Consumables

5.2.3.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3.2. Reagents

5.2.3.2.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3.3. Stains

5.2.3.3.1. Stains Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3.4. Others

5.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Hematology Diagnostics Market By Test Type

6.1. Introduction

6.2. Hematology Diagnostics Revenue By Test Type

6.2.1. Hematology Diagnostics Revenue (USD Billion) and Forecast, By Test Type, 2018-2030

6.2.2. Blood Count

6.2.2.1. Blood Count Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Platelet Function

6.2.3.1. Platelet Function Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Hemoglobin

6.2.4.1. Hemoglobin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.5. Hematocrit

6.2.5.1. Hematocrit Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Hematology Diagnostics Market By End-Use

7.1. Introduction

7.2. Hematology Diagnostics Revenue By End-Use

7.2.1. Hematology Diagnostics Revenue (USD Billion) and Forecast, By End-Use, 2018-2030

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Clinics

7.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. North America Hematology Diagnostics Market By Country

8.1. North America Hematology Diagnostics Market Overview

8.2. U.S.

8.2.1. U.S. Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

8.2.2. U.S. Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

8.2.3. U.S. Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

8.3. Canada

8.3.1. Canada Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

8.3.2. Canada Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

8.3.3. Canada Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

8.4. North America PEST Analysis

CHAPTER 9. Europe Hematology Diagnostics Market By Country

9.1. Europe Hematology Diagnostics Market Overview

9.2. U.K.

9.2.1. U.K. Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

9.2.2. U.K. Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

9.2.3. U.K. Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

9.3. Germany

9.3.1. Germany Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

9.3.2. Germany Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

9.3.3. Germany Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

9.4. France

9.4.1. France Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

9.4.2. France Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

9.4.3. France Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

9.5. Spain

9.5.1. Spain Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

9.5.2. Spain Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

9.5.3. Spain Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

9.6. Rest of Europe

9.6.1. Rest of Europe Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

9.6.2. Rest of Europe Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

9.6.3. Rest of Europe Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Hematology Diagnostics Market By Country

10.1. Asia Pacific Hematology Diagnostics Market Overview

10.2. China

10.2.1. China Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.2.2. China Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.2.3. China Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.3. Japan

10.3.1. Japan Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.3.2. Japan Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.3.3. Japan Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.4. India

10.4.1. India Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.4.2. India Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.4.3. India Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.5. Australia

10.5.1. Australia Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.5.2. Australia Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.5.3. Australia Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.6. South Korea

10.6.1. South Korea Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.6.2. South Korea Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.6.3. South Korea Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

10.7.2. Rest of Asia-Pacific Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

10.7.3. Rest of Asia-Pacific Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Hematology Diagnostics Market By Country

11.1. Latin America Hematology Diagnostics Market Overview

11.2. Brazil

11.2.1. Brazil Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

11.2.2. Brazil Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

11.2.3. Brazil Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

11.3. Mexico

11.3.1. Mexico Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

11.3.2. Mexico Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

11.3.3. Mexico Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

11.4. Rest of Latin America

11.4.1. Rest of Latin America Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

11.4.2. Rest of Latin America Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

11.4.3. Rest of Latin America Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Hematology Diagnostics Market By Country 

12.1. Middle East & Africa Hematology Diagnostics Market Overview

12.2. GCC

12.2.1. GCC Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

12.2.2. GCC Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

12.2.3. GCC Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

12.3. South Africa

12.3.1. South Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

12.3.2. South Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

12.3.3. South Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030

12.4.2. Rest of Middle East & Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2018-2030

12.4.3. Rest of Middle East & Africa Hematology Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Hematology Diagnostics Market

13.1. Hematology Diagnostics Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Hematology Diagnostics Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Abbott Laboratories

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2021

14.1.3.2. Abbott Laboratories 2021 Hematology Diagnostics Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Ortho Clinical Diagnostics

14.3. Sysmex Corporation

14.4. Boule Diagnostics

14.5. F. Hoffmann-La Roche Ltd.

14.6. Drew Scientific

14.7. Bio-Rad Laboratories

14.8. EKF Diagnostics

14.9. Beckman Coulter, Inc.

14.10. HORIBA, Ltd.